Startseite Medizin Chymotrypsin effects on the determination of sperm parameters and seminal biochemistry markers
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Chymotrypsin effects on the determination of sperm parameters and seminal biochemistry markers

  • Fang Chen , Jin-Chun Lu , Hui-Ru Xu , Yu-Feng Huang und Nian-Qing Lu
Veröffentlicht/Copyright: 21. September 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Few reports of the effects of treatment with chymotrypsin on the determination of sperm parameters and seminal biochemistry markers are documented.

Methods: Sperm parameters of 63 liquefied and 27 non-liquefied samples, untreated or treated with chymotrypsin, were evaluated using computer-assisted semen analysis. In addition, biochemistry markers such as γ-glutamyltranspeptidase, α-glucosidase and fructose in 50 liquefied and 39 non-liquefied samples, untreated or treated with chymotrypsin, were determined.

Results: Treatment with chymotrypsin had no effect on sperm concentration, motility, motility a and b, straightness, curvilinear velocity, straight line velocity, average path velocity and beat cross frequency in both liquefied and non-liquefied semen. However, linearity (p=0.025) decreased and the amplitude of the lateral head (p=0.029) increased significantly in non-liquefied semen after treatment with chymotrypsin. The levels of γ-glutamyltranspeptidase, α-glucosidase and fructose in seminal plasma were unaffected by chymotrypsin, regardless of liquefaction status.

Conclusions: Chymotrypsin had no effects on the detection of sperm parameters and biochemistry markers, and could be used to treat non-liquefied samples before semen analysis in the andrology laboratory.

Clin Chem Lab Med 2006;44:1335–9.


Corresponding authors: Prof. Yu-Feng Huang and Dr. Jin-Chun Lu, Department of Reproduction and Genetics, Nanjing General Hospital, PLA, 305 East Zhongshan Road, Nanjing 210002, P.R. China Phone: +86-25-52999865

References

1. Lwaleed BA, Greenfield RS, Hicks J, Birch BR, Cooper AJ. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen. J Androl 2005; 26:146–52.Suche in Google Scholar

2. Lee C, Keefer M, Zhao ZW, Kroes R, Berg L, Liu XX, et al. Demonstration of the role of prostate-specific antigen in semen liquefaction by two-dimensional electrophoresis. J Androl 1989; 10:432–8.10.1002/j.1939-4640.1989.tb00134.xSuche in Google Scholar

3. Bilhartz DL, Tindall DJ, Oesterling JE. Prostate-specific antigen and prostatic acid phosphatase: biomolecular and physiologic characteristics. Urology 1991; 38:95–102.10.1016/S0090-4295(05)80066-4Suche in Google Scholar

4. Seregni E, Botti C, Ballabio G, Bombardieri E. Biochemical characteristics and recent biological knowledge on prostate-specific antigen. Tumori 1996; 82:72–7.10.1177/030089169608200116Suche in Google Scholar

5. Robert M, Gagnon C. Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein. Cell Mol Life Sci 1999; 55:944–60.10.1007/s000180050346Suche in Google Scholar PubMed

6. Yoshida K, Yamasaki T, Yoshiike M, Takano S, Sato I, Iwamoto T. Quantification of seminal plasma motility inhibitor/semenogelin in human seminal plasma. J Androl 2003; 24:878–84.10.1002/j.1939-4640.2003.tb03139.xSuche in Google Scholar PubMed

7. Jonsson M, Linse S, Frohm B, Lundwall A, Malm J. Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen. Biochem J 2005; 38:447–53.10.1042/BJ20041424Suche in Google Scholar PubMed PubMed Central

8. Wersch JW, De Vries-Hanje JC, Ubachs JM. Coagulation and fibrinolysis markers in seminal plasma of patients under evaluation for involuntary childlessness. Eur J Clin Chem Clin Biochem 1992; 30:467–71.10.1515/cclm.1992.30.8.467Suche in Google Scholar PubMed

9. Park JY, Yoshimura Y, Nozawa S, Umeda T, Askihama S, Matsuda Y. Fibrinogen-like substance and thrombin-like enzyme in seminal plasma: coagulation system of human semen. Arch Androl 1997; 38:29–36.10.3109/01485019708988529Suche in Google Scholar PubMed

10. Lwaleed BA, Greenfied R, Stewart A, Birch B, Cooper AJ. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb Haemost 2004; 92:752–66.10.1160/TH04-03-0142Suche in Google Scholar PubMed

11. Chatterjee S, Laloraya M, Kumar PG. Free radical-induced liquefaction of ejaculated human semen: a new dimension in semen biochemistry. Arch Androl 1997; 38:107–11.10.3109/01485019708987887Suche in Google Scholar PubMed

12. Wilson VB, Bunge RG. Infertility and semen non-liquefaction. J Urol 1975; 113:509–10.10.1016/S0022-5347(17)59513-0Suche in Google Scholar

13. Vermeiden JP, Bernardus RE, ten Brug CS, Statema-Lohmeijer CH, Willemsen-Brugma AM, Schoemaker J. Pregnancy rate is significantly higher in in vitro fertilization procedure with spermatozoa isolated from nonliquefying semen in which liquefaction is induced by α-amylase. Fertil Steril 1989; 51:149–52.10.1016/S0015-0282(16)60444-2Suche in Google Scholar

14. Gonzalez-Estrella JA, Coney P, Ostash K, Karabinus D. Dithiothreitol effects on the viscosity and quality of human semen. Fertil Steril 1994; 62:1238–43.10.1016/S0015-0282(16)57192-1Suche in Google Scholar

15. Barmatz MJ, Karabinus DS, Dalkin BL. Dithiothreitol effects on human sperm quality. J Urol 1994; 152:2287–90.10.1016/S0022-5347(17)31659-2Suche in Google Scholar

16. WHO Laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 3rd ed. Cambridge: Cambridge University Press, 1992.Suche in Google Scholar

17. Freischem CW, Bordt J, Hanker JP, Schneider HP, Nie-schlag E. Pregnancy after treatment of ejaculate with alpha-chymotripsine because of failure to liquefy [German]. Geburtshilfe Frauenheilkd 1983; 43:490–1.10.1055/s-2008-1036562Suche in Google Scholar

18. Bollendorf A, Check JH, Katsoff D, Fedele A. The use of chymotrypsin/galactose to treat spermatozoa bound with anti-sperm antibodies prior to intra-uterine insemination. Hum Reprod 1994; 9:484–8.10.1093/oxfordjournals.humrep.a138532Suche in Google Scholar

19. Katsoff D, Check JH. Two methods of achieving pregnancies despite subnormal hypo-osmotic swelling test scores. Fertil Steril 1997; 68:549–51.10.1016/S0015-0282(97)00234-3Suche in Google Scholar

20. Check JH. Sperm may be associated with subfertility independent of oocyte fertilization. Clin Exp Obstet Gynecol 2005; 32:5–8.Suche in Google Scholar

21. Huang YF, Xu RJ editors. Nan Ke Zhen Duan Xue [Chinese]. Shanghai: Shanghai 2nd Military Medical University Press, 1999.Suche in Google Scholar

22. Wijchman JG, de Wolf BT, Graafe R, Arts EG. Variation in semen parameters derived from computer-aided semen analysis, within donors and between donors. J Androl 2001; 22:773–80.Suche in Google Scholar

23. Gonzalez Buitrago JM, Garcia Diez LC, Meza S, Juanes M. γ-Glutamyl-transferase activity in human semen. Application to fertility studies. Med Clin 1981; 76:401–4.Suche in Google Scholar

24. Guerin JF, Czyba JC. Relationships between seminal enzymes and fertility. Ann Endocrinol 1981; 42:423–8.Suche in Google Scholar

25. Carpino A, De Sanctis V, Siciliano L, Maggiolini M, Vivacqua A, Pinamonti A, et al. Epididymal and sex accessory gland secretions in transfusion-dependent beta-thalassemic patients: evidence of an impaired prostatic function. Exp Clin Endocrinol Diabetes 1997; 105:169–74.10.1055/s-0029-1211747Suche in Google Scholar PubMed

26. Lu JC, Chen F, Xu HR, Huang YF, Lu NQ. Preliminary investigations on the standardization and quality control for the determination of acid phosphatase activity in seminal plasma. Clin Chim Acta 2007; 375:76–81.10.1016/j.cca.2006.06.005Suche in Google Scholar PubMed

27. Carpino A, Siciliano L. Unaltered protein pattern/genital tract secretion marker levels in seminal plasma of highly viscous human ejaculates. Arch Androl 1998; 41:31–5.10.3109/01485019808988543Suche in Google Scholar PubMed

28. Aafjes JH, Blijenberg BG, Wolffensperger-van Oort HJ, Schenck PE. Enzyme activity of human ejaculates, relation with abnormal liquefaction. Andrologia 1985; 17:87–91.10.1111/j.1439-0272.1985.tb00964.xSuche in Google Scholar PubMed

29. Yang GZ, Zhu PY, Hu YA, Ge YF. Examination and significance of seminal prostate specific antigen in infertile patients. Zhonghua Nan Ke Xue 2003; 9:596–8.Suche in Google Scholar

30. Mandal A, Bhattacharvya AK. Phosphate, zinc, calcium, citric acid, and acid phosphatase in human ejaculates as related to coagulation/liquefaction. Arch Androl 1987; 19:275–83.10.3109/01485018708986828Suche in Google Scholar PubMed

31. Aafjes JH, Wolffensperger-van Oort HJ, Schenck PE. γ-Glutamyltranspeptidase and β-glucuronidase in human ejaculates. Relation with abnormal liquefaction. Andrologia 1983; 15:661–5.10.1111/j.1439-0272.1983.tb00186.xSuche in Google Scholar PubMed

32. WHO Laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th ed. Cambridge: Cambridge University Press, 1999.Suche in Google Scholar

Received: 2006-6-29
Accepted: 2006-9-6
Published Online: 2011-9-21
Published in Print: 2006-11-1

©2006 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Renal function – estimation of glomerular filtration rate
  2. Research translation: a new frontier for clinical laboratories
  3. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population
  4. MTRR 66A>G polymorphism in relation to congenital heart defects
  5. Increased homocysteine in heart failure: a result of renal impairment?
  6. Urine flow cytometry and detection of glomerular hematuria
  7. Chymotrypsin effects on the determination of sperm parameters and seminal biochemistry markers
  8. Evaluation of cardiac involvement following major orthopedic surgery
  9. Increased sensitivity in detecting renal impairments by quantitative measurement of marker protein excretion compared to detection of pathological particles in urine sediment analysis
  10. Clinical chemistry reference values for 75-year-old apparently healthy persons
  11. Serum pro-hepcidin concentrations and their responses to oral iron supplementation in healthy subjects manifest considerable inter-individual variation
  12. Comparability of five analytical systems for the determination of triiodothyronine, thyroxine and thyroid-stimulating hormone
  13. Automated analysis of pleural fluid total and differential leukocyte counts with the Sysmex XE-2100
  14. Automation and validation of a fast method for the assessment of in vivo oxidative stress levels
  15. Analytical validation of the new plasma calibrated Accu-Chek® Test Strips (Roche Diagnostics)
  16. Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: Bi-insulin IRMA preliminary assessment
  17. Analytical and clinical evaluation of a new heart-type fatty acid-binding protein automated assay
  18. A caveat for OV-Monitor (CA 125 antigen) measurement: something is improving, something is not
  19. Reply to the letter written by Dorizzi et al.
Heruntergeladen am 7.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.253/html?lang=de
Button zum nach oben scrollen